INmune Bio Inc (INMB) Price Prediction & ForecastINMBINmune Bio Inc

Alphio's INMB stock price prediction model matches the current INmune Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.12 (+0.15%). The 1-week path is $1.11 (-0.92%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Currently, INmune Bio Inc (INMB) is not a strong buy. The stock is trading at $1.38, which is significantly below its 52-week high of $2.60, indicating a decline of about 47%. Additionally, the RSI is at 29.024, suggesting that the stock is oversold. However, the forward P/E ratio is 0, indicating no expected earnings growth in the near term, which raises concerns about the company's profitability. The main risk is the significant net loss reported in Q2, which was $1.27 million, down from $24.46 million the previous year, but still indicates ongoing financial challenges. Therefore, while there are some positive catalysts such as the submission of an Orphan Drug Application, the overall financial performance and technical indicators suggest holding rather than buying at this time.

INmune Bio Inc (INMB) last closed at $1.12, losing -4.68%. These facts feed the 1-day and 1-week INMB price prediction above.